tiprankstipranks
DEMAE-CAN (DE:1H7)
FRANKFURT:1H7
Germany Market

DEMAE-CAN (1H7) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
5Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
DEMAE-CAN’s (1H7) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting DEMAE-CAN is a Sell.
DEMAE-CAN’s (1H7) 20-Day exponential moving average is 1.30, while DEMAE-CAN’s (1H7) share price is €1.32, making it a Buy.
DEMAE-CAN’s (1H7) 50-Day exponential moving average is 1.35, while DEMAE-CAN’s (1H7) share price is €1.32, making it a Sell.

DEMAE-CAN (1H7) Pivot Points

Mar 12, 2025, 09:14 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.28
1.28
1.28
1.28
1.28
1.28
1.28
Fibonacci
1.28
1.28
1.28
1.28
1.28
1.28
1.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

DEMAE-CAN (1H7) Moving Averages

Mar 12, 2025, 09:14 PM
Period
Simple
Exponential
MA5
1.27Buy
1.28Buy
MA10
1.27Buy
1.28Buy
MA20
1.30Buy
1.30Buy
MA50
1.36Sell
1.35Sell
MA100
1.42Sell
1.41Sell
MA200
1.46Sell
1.48Sell
DEMAE-CAN’s (1H7) 10-Day exponential moving average is 1.28, while DEMAE-CAN’s (1H7) share price is €1.32, making it a Buy.
DEMAE-CAN’s (1H7) 100-Day exponential moving average is 1.41, while DEMAE-CAN’s (1H7) share price is €1.32, making it a Sell.
DEMAE-CAN’s (1H7) stock price is €1.32 and DEMAE-CAN’s (1H7) 50-day simple moving average is 1.36, creating a Sell signal.
DEMAE-CAN’s (1H7) stock price is €1.32 and DEMAE-CAN’s (1H7) 100-day simple moving average is 1.42, creating a Sell signal.
DEMAE-CAN’s (1H7) stock price is €1.32 and DEMAE-CAN’s (1H7) 200-day simple moving average is 1.46, creating a Sell signal.

DEMAE-CAN (1H7) Technical Indicators

Mar 12, 2025, 09:14 PM
Name
Value
Implied Action
RSI (14)
51.49
Neutral
STOCH (9,6)
72.22
Neutral
STOCHRSI (14)
62.50
Neutral
MACD (12,26)
-0.03
Sell
ADX (14)
19.63
Buy
Williams %R
0.00
Buy
CCI (14)
49.95
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
62.03
Neutral
ROC
2.33
Buy
DEMAE-CAN’s (1H7) Relative Strength Index (RSI) is 51.49, creating a Neutral signal.
DEMAE-CAN’s (1H7) Trend Strength Indicator (ADX) is 19.63, creating a Buy signal.
DEMAE-CAN’s (1H7) Commodity Channel Index (CCI) is 49.95, creating a Neutral signal.
DEMAE-CAN’s (1H7) Price Rate of Change (ROC) is 2.33, creating a Buy signal.

FAQ

Is 1H7 a Buy, Hold, or Sell?
Based on 1H7’s technical indicators, 1H7 is a Hold.
    What is 1H7’s RSI (14)?
    1H7’s RSI (14) is 51.49, which suggests 1H7 is a Neutral.
      What is 1H7’s MACD?
      1H7’s MACD is -0.03, which suggests 1H7 is a Sell.
        What is 1H7’s 5-day moving average?
        1H7’s 5-day moving average is 1.27, which suggests 1H7 is a Buy.
          What is 1H7’s 20-day moving average?
          1H7 20-day moving average is 1.30, which suggests 1H7 is a Buy.
            What is 1H7’s 50-day moving average?
            1H7’s 50-day moving average is 1.36, which suggests 1H7 is a Sell.
              What is 1H7’s 200-day moving average?
              1H7’s 200-day moving average is 1.46, which suggests 1H7 is a Sell.
                What is 1H7’s Williams % R (14)?
                1H7’s Williams % R (14) is 0.00, which suggests 1H7 is a Buy.
                  What is 1H7’s CCI (14)?
                  1H7’s CCI (14) is 49.95, which suggests 1H7 is a Neutral.
                    What is the share price of DEMAE-CAN?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis